Clinical Trials Directory

Trials / Completed

CompletedNCT05585112

Articaine 4% Versus Lidocaine 2% for Local Anesthesia of MIH-affected Maxillary Molars

Comparative Study of Articaine 4% Versus Lidocaine 2% in Local Anesthesia and Permanent Maxillary First Molars Affected by MIH.

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Tishreen University · Academic / Other
Sex
All
Age
6 Years – 12 Years
Healthy volunteers
Accepted

Summary

Comparison of injection pain with lidocaine and articaine. Comparison of the efficacy of lidocaine and articaine during treatment of MIH- maxillary molars. Design: A randomized, controlled, crossover, Triple-blinding clinical study including twenty six cooperative children, aged 6-12years old

Detailed description

Background and Aims: Some dentists have difficulty obtaining effective anesthesia when treating MIH molars. There are no studies comparing the effectiveness of lidocaine and articaine in MIH-maxillary molars. Design: A randomized, controlled, crossover, Triple-blinding clinical study including twenty six cooperative children , aged 6-12 years old. Each child was randomly assigned to either articaine 4% or lidocaine 2% in their first session with the second solution being used at the second session.

Conditions

Interventions

TypeNameDescription
DRUGLidocaine 2%The child will be injected with lidocaine 2%,after that the treatment will be completed , Pain during injection and treatment will be assessed using the FLACC scale and pain after injection and treatment will be evaluated using the Wong-Baker faces pain rating scale
DRUGArticaine 4%The child will be injected with 4% Articaine, after that the treatment will be completed , Pain during injection and treatment will be assessed using the FLACC scale and Wong-Baker faces pain rating scale

Timeline

Start date
2022-10-17
Primary completion
2022-12-05
Completion
2022-12-25
First posted
2022-10-18
Last updated
2023-05-03

Locations

1 site across 1 country: Syria

Source: ClinicalTrials.gov record NCT05585112. Inclusion in this directory is not an endorsement.